Touch Haematology Facebook ad: “touchPANEL DISCUSSION”

Ran for 9 days, from March 9 to March 18, 2026, the last day Crush saw it.

Run by Touch Haematology on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)

Want an ad like this for your product?

Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.

Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.

About this ad

Meta Ad Library ID: 3970449253099424
Platforms: Facebook, Instagram, Audience Network, Messenger and Threads
Relaunches: 4
EU reach: 102,547

How we count

Ad text

PNH management is evolving, are your treatment strategies keeping pace? In this accredited, expert-led panel discussion, Prof. Bruno Fattizzo, Dr Austin Kulasekararaj and Dr Srikanth Nagalla examine: ✔ Emerging understanding of PNH pathophysiology and its diagnostic implications ✔ Comparative efficacy, safety and PRO data across established and newer complement inhibitors ✔ Evidence-based strategies for managing breakthrough haemolysis and suboptimal response ✔ Practical considerations for switching therapy and long-term risk mitigation If you manage patients with PNH, this activity provides actionable, clinically relevant insights to support personalised treatment decisions. Access the activity today and stay current with the latest data. This activity is funded by an independent medical education grant from Alexion Pharma GmbH. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

Where the ad sends people

touchhaematologyime.org

touchPANEL DISCUSSION

Learn more: touchhaematologyime.org